Background: The factor affecting the liver's healing process after resection in liver malignancy is liver fibrosis. Bovine Colostrum (BC), as one of the anti-fibrosis products of the liver, improves hepatic fibrosis and reduces hepatocyte damage caused by carbon tetrachloride (CCl4). Meanwhile, Mesenchymal Stem Cell (MSC) is a new therapeutic source after resection. MSC is able to differentiate into specific cells in the healing process. This study aims to determine the effects of BC, MSC, and a combination of both in terms of increasing Alkaline Phosphatase (ALP) and Takeda G-Protein Coupled Receptor-5 (TGR5) levels in Wistar rats post hepatectomy 50% with liver fibrosis.
Methods: This study is an experimental study with a randomized control trial design. Subjects were 25 Wistar rats (Rattus norvegicus) which were divided into 5 groups: Sham (surgery only), K (Control), K1 (CCL4 +BC), K2 (CCL4 + MSC), and K3 (CCL4 + MSC +BC). Blood was also taken to assess ALP and TGR5 at Day-3, Day-7, and Day-10 of treatment. Data were analyzed using SPSS version 25 for Windows.
Results: A significant differences are found in ALP in the Sham group with K2 (p = 0.014) and the K2 group with K1 (p=0.026) on day 10. Significant differences in TGR5 are found in the Sham and K2 groups (p=0.009), control with K2 (p=0.014), K2 with K1 (p=0.007) on day 3. On day 7 in the control group with the combination (p=0.013). The test results showed that TGR5 on day 3 had a moderate significant strong correlation on ALP levels on day 10 (r=0.596; p=0.014).
Conclusion: The combination of BC and MSC was not better than the administration of BC or MSC only in increasing ALP and TGR5 levels in rats with liver fibrosis after hepatectomy 50%.
Based on this study, the administration of MSC is recommended.